The Research and Development team at Aarvik Therapeutics is responsible for the discovery and optimization of innovative therapeutic molecules targeting oncology. They leverage a modular antibody platform to enhance therapeutic indices while collaborating across data sciences, research operations, and chemistry to ensure the efficient development of novel treatments. This multidisciplinary approach drives the advancement of next-generation therapies in the fight against cancer.
View all